255 related articles for article (PubMed ID: 35057549)
1. Krill Oil Inhibits NLRP3 Inflammasome Activation in the Prevention of the Pathological Injuries of Diabetic Cardiomyopathy.
Sun X; Sun X; Meng H; Wu J; Guo X; Du L; Wu H
Nutrients; 2022 Jan; 14(2):. PubMed ID: 35057549
[TBL] [Abstract][Full Text] [Related]
2. Sirtuin 3 deficiency exacerbates diabetic cardiomyopathy via necroptosis enhancement and NLRP3 activation.
Song S; Ding Y; Dai GL; Zhang Y; Xu MT; Shen JR; Chen TT; Chen Y; Meng GL
Acta Pharmacol Sin; 2021 Feb; 42(2):230-241. PubMed ID: 32770173
[TBL] [Abstract][Full Text] [Related]
3. Synergistic cardioptotection by tilianin and syringin in diabetic cardiomyopathy involves interaction of TLR4/NF-κB/NLRP3 and PGC1a/SIRT3 pathways.
Yao J; Li Y; Jin Y; Chen Y; Tian L; He W
Int Immunopharmacol; 2021 Jul; 96():107728. PubMed ID: 33971494
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of miR-223 attenuates the NLRP3 inflammasome activation, fibrosis, and apoptosis in diabetic cardiomyopathy.
Xu D; Zhang X; Chen X; Yang S; Chen H
Life Sci; 2020 Sep; 256():117980. PubMed ID: 32561396
[TBL] [Abstract][Full Text] [Related]
5. NLRP3 gene silencing ameliorates diabetic cardiomyopathy in a type 2 diabetes rat model.
Luo B; Li B; Wang W; Liu X; Xia Y; Zhang C; Zhang M; Zhang Y; An F
PLoS One; 2014; 9(8):e104771. PubMed ID: 25136835
[TBL] [Abstract][Full Text] [Related]
6. H3 Relaxin Protects Against Myocardial Injury in Experimental Diabetic Cardiomyopathy by Inhibiting Myocardial Apoptosis, Fibrosis and Inflammation.
Zhang X; Pan L; Yang K; Fu Y; Liu Y; Chi J; Zhang X; Hong S; Ma X; Yin X
Cell Physiol Biochem; 2017; 43(4):1311-1324. PubMed ID: 28992627
[TBL] [Abstract][Full Text] [Related]
7. Non-Invasive Local Acoustic Therapy Ameliorates Diabetic Heart Fibrosis by Suppressing ACE-Mediated Oxidative Stress and Inflammation in Cardiac Fibroblasts.
Weng L; Li L; Zhao K; Xu T; Mao Y; Shu H; Chen X; Chen J; Wu J; Guo X; Tu J; Zhang D; Sun W; Kong X
Cardiovasc Drugs Ther; 2022 Jun; 36(3):413-424. PubMed ID: 35156147
[TBL] [Abstract][Full Text] [Related]
8. The Chinese herbal medicine Fufang Zhenzhu Tiaozhi protects against diabetic cardiomyopathy by alleviating cardiac lipotoxicity-induced oxidative stress and NLRP3-dependent inflammasome activation.
Yan M; Li L; Wang Q; Shao X; Luo Q; Liu S; Li Y; Wang D; Zhang Y; Diao H; Rong X; Guo J
Biomed Pharmacother; 2022 Apr; 148():112709. PubMed ID: 35190353
[TBL] [Abstract][Full Text] [Related]
9. Gypenosides improve diabetic cardiomyopathy by inhibiting ROS-mediated NLRP3 inflammasome activation.
Zhang H; Chen X; Zong B; Yuan H; Wang Z; Wei Y; Wang X; Liu G; Zhang J; Li S; Cheng G; Wang Y; Ma Y
J Cell Mol Med; 2018 Sep; 22(9):4437-4448. PubMed ID: 29993180
[TBL] [Abstract][Full Text] [Related]
10. Pyrroloquinoline quinone ameliorates diabetic cardiomyopathy by inhibiting the pyroptosis signaling pathway in C57BL/6 mice and AC16 cells.
Qu XF; Zhai BZ; Hu WL; Lou MH; Chen YH; Liu YF; Chen JG; Mei S; You ZQ; Liu Z; Zhang LJ; Zhang YH; Wang Y
Eur J Nutr; 2022 Jun; 61(4):1823-1836. PubMed ID: 34997266
[TBL] [Abstract][Full Text] [Related]
11. Cathelicidin-WA ameliorates diabetic cardiomyopathy by inhibiting the NLRP3 inflammasome.
Peng M; Liu Y; Xu Y; Li L; Li Y; Yang H
Cell Cycle; 2021 Nov; 20(21):2278-2290. PubMed ID: 34585633
[TBL] [Abstract][Full Text] [Related]
12. PGC-1α inhibits the NLRP3 inflammasome via preserving mitochondrial viability to protect kidney fibrosis.
Nam BY; Jhee JH; Park J; Kim S; Kim G; Park JT; Yoo TH; Kang SW; Yu JW; Han SH
Cell Death Dis; 2022 Jan; 13(1):31. PubMed ID: 35013155
[TBL] [Abstract][Full Text] [Related]
13. Rosuvastatin alleviates diabetic cardiomyopathy by inhibiting NLRP3 inflammasome and MAPK pathways in a type 2 diabetes rat model.
Luo B; Li B; Wang W; Liu X; Liu X; Xia Y; Zhang C; Zhang Y; Zhang M; An F
Cardiovasc Drugs Ther; 2014 Feb; 28(1):33-43. PubMed ID: 24254031
[TBL] [Abstract][Full Text] [Related]
14. Klotho improves diabetic cardiomyopathy by suppressing the NLRP3 inflammasome pathway.
Li X; Li Z; Li B; Zhu X; Lai X
Life Sci; 2019 Oct; 234():116773. PubMed ID: 31422095
[TBL] [Abstract][Full Text] [Related]
15. Attenuation of ROS/Chloride Efflux-Mediated NLRP3 Inflammasome Activation Contributes to Alleviation of Diabetic Cardiomyopathy in Rats after Sleeve Gastrectomy.
Li S; Dong S; Shi B; Xu Q; Li L; Wang S; Zhang W; Zhong M; Zhu J; Cheng Y; Zhang G; Hu S
Oxid Med Cell Longev; 2022; 2022():4608914. PubMed ID: 35498125
[TBL] [Abstract][Full Text] [Related]
16. Thrombin receptor PAR4 drives canonical NLRP3 inflammasome signaling in the heart.
Fender AC; Kleeschulte S; Stolte S; Leineweber K; Kamler M; Bode J; Li N; Dobrev D
Basic Res Cardiol; 2020 Jan; 115(2):10. PubMed ID: 31912235
[TBL] [Abstract][Full Text] [Related]
17. Metformin Inhibits the NLRP3 Inflammasome via AMPK/mTOR-dependent Effects in Diabetic Cardiomyopathy.
Yang F; Qin Y; Wang Y; Meng S; Xian H; Che H; Lv J; Li Y; Yu Y; Bai Y; Wang L
Int J Biol Sci; 2019; 15(5):1010-1019. PubMed ID: 31182921
[TBL] [Abstract][Full Text] [Related]
18. NLRP3 inflammasome mechanism and therapeutic targets in diabetic cardiomyopathy.
Sun Q; Guo W; Yue T; Wang L; Mou H
Gac Med Mex; 2023; 159(3):255-261. PubMed ID: 37494725
[TBL] [Abstract][Full Text] [Related]
19. Growth differentiation factor 11 regulates high glucose-induced cardiomyocyte pyroptosis and diabetic cardiomyopathy by inhibiting inflammasome activation.
Zhang J; Wang G; Shi Y; Liu X; Liu S; Chen W; Ning Y; Cao Y; Zhao Y; Li M
Cardiovasc Diabetol; 2024 May; 23(1):160. PubMed ID: 38715043
[TBL] [Abstract][Full Text] [Related]
20. Melatonin alleviates cardiac fibrosis via inhibiting lncRNA MALAT1/miR-141-mediated NLRP3 inflammasome and TGF-β1/Smads signaling in diabetic cardiomyopathy.
Che H; Wang Y; Li H; Li Y; Sahil A; Lv J; Liu Y; Yang Z; Dong R; Xue H; Wang L
FASEB J; 2020 Apr; 34(4):5282-5298. PubMed ID: 32067273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
